Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Children with focal refractory epilepsy will be routinely included in the collection of
history, blood routine, biochemistry, EEG, MRI and 18F-FDG PET to determine the location of
the epileptogenic focus and to assess the severity of the disease. This international
multicenter clinical trial uses a double-blind, randomized, controlled study to evaluate the
safety and efficacy of LCM in clinical applications in children with epilepsy.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
Juntendo University Michigan State University RIKEN Technische Universität München Tongji Hospital University of California, Los Angeles